Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Swankie who wrote (5975)	1/26/1999 11:11:00 PM
From: trilobyte	Read Replies (1) of 6136

HOW COULD THEY DO THIS!!! AGPH is selling itself out! This is so ridiculous. With the oncology division soon to have been on a different balance sheet, AGPH would've been been a highly profitable biotech with tons of exciting things in the pipeline. What's that worth? Certainly more than a measley 60$, no premium over the current price. could AGPH see a bad future for viracept? That would seem contrary to most indications. If that's the case, it could explain the sudden sell out. but really, AGPH had the potential to become huge and the CEO didn't care to take it to the next level. There are many words to describe such "gutlessness"... darn is this frustrating; what a missed opportunity. Trilobyte

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next